Ultralife Corp has a consensus price target of $14 based on the ratings of 1 analysts. The high is $14 issued by Benchmark on June 27, 2024. The low is $14 issued by Benchmark on June 27, 2024. The 3 most-recent analyst ratings were released by Benchmark on June 27, 2024, March 5, 2024, and August 8, 2023, respectively. With an average price target of $13 between Benchmark, there's an implied 9.80% upside for Ultralife Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/27/2024 | Buy Now | 18.25% | Benchmark | Josh Sullivan | $13 → $14 | Maintains | Buy | Get Alert |
03/05/2024 | Buy Now | 9.8% | Benchmark | Josh Sullivan | $12 → $13 | Maintains | Buy | Get Alert |
08/08/2023 | Buy Now | 1.36% | Benchmark | Josh Sullivan | → $12 | Reiterates | Buy → Buy | Get Alert |
The latest price target for Ultralife (NASDAQ:ULBI) was reported by Benchmark on June 27, 2024. The analyst firm set a price target for $14.00 expecting ULBI to rise to within 12 months (a possible 18.25% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Ultralife (NASDAQ:ULBI) was provided by Benchmark, and Ultralife maintained their buy rating.
There is no last upgrade for Ultralife
There is no last downgrade for Ultralife.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ultralife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ultralife was filed on June 27, 2024 so you should expect the next rating to be made available sometime around June 27, 2025.
While ratings are subjective and will change, the latest Ultralife (ULBI) rating was a maintained with a price target of $13.00 to $14.00. The current price Ultralife (ULBI) is trading at is $11.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.